Transarterial chemoembolisation in patients with hepatocellular carcinoma: low-dose doxorubicin reduces post-embolisation syndrome without affecting survival—prospective interventional study

BACKGROUND: No chemotherapeutic agents have been standardised for transarterial chemoembolisation (TACE). In particular, doxorubicin has no defined optimal dosage in TACE procedures. We compared low versus currently used dose of doxorubicin for TACE in patients with hepatocellular carcinoma (HCC) in...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Eur Radiol Exp
Main Authors: Bessar, Ahmed A., Farag, Ahmed, Abdel Monem, Sameh M., Wadea, Fady M., Shaker, Shady E., Ebada, Mahmoud Ahmed, Bessar, Manar A.
Format: Artigo
Sprog:Inglês
Udgivet: Springer International Publishing 2021
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7921261/
https://ncbi.nlm.nih.gov/pubmed/33649930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s41747-021-00204-6
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker